EU backs changing monkeypox vaccine injection method to boost supply

EU Regulator Recommends US Plan to Stretch Monkeypox Vaccine

Europe’s drug regulator on Friday recommended an alternative monkeypox vaccine dosing regimen aimed at stretching the limited global supply of doses, similar to the United States’ approach. According to a clinical trial of around 500 adults, a smaller dose given just beneath the skin produced similar levels of antibodies as a normal subcutaneous injection that requires five times as much vaccine. Following advice from the European regulator’s em…

EU Regulator OKs Plan to Stretch Monkeypox Vaccine Supplies

London - A smaller dose of the monkeypox vaccine appears to still be effective and can be used to stretch the current supply by five times, the European

EU follows US lead, approves plan to stretch monkeypox vaccine supplies

A sign for monkeypox vaccinations is shown at a vaccination site, Wednesday, Aug. 10, 2022, in Miami Beach, Fla. Lynne Sladky/APEU follows US lead, approves plan to stretch monkeypox vaccine supplies Abigail Adcox August 19, 02:48 PMAugust 19, 02:48 PM Video Embed The European Union's drug regulator has approved a strategy for countries to increase their monkeypox vaccine supply by five times by injecting a s…

EU Drug Regulator Backs New Monkeypox Jab Method To Stretch Vaccine Supply

The EU's drug regulator on Friday authorised a new technique for monkeypox injections that will allow up to five times more people to be innoculated as supplies of the vaccine run short.

EU backs changing monkeypox vaccine injection method to boost supply

The advice is in line with the so-called fractional dosing approach endorsed by US regulators in which one vial of the vaccine can be used to administer up to five separate doses - instead of a single dose - by injecting a smaller amount in between layers of the skin (intradermal injection).

Monkeypox: EU approves plan to stretch vaccine supply

A shortage of a smallpox vaccine, used to treat the current outbreak of monkeypox, prompted the move by the EU drugs regulator. The temporary injection method will allow five times more people to be treated.